These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38078799)

  • 21. Role of SLC7A11/xCT in Ovarian Cancer.
    Fantone S; Piani F; Olivieri F; Rippo MR; Sirico A; Di Simone N; Marzioni D; Tossetta G
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of H2A ubiquitination and SLC7A11 expression by BAP1 and PRC1.
    Zhang Y; Koppula P; Gan B
    Cell Cycle; 2019 Apr; 18(8):773-783. PubMed ID: 30907299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glial Glutamate Transporter-Mediated Plasticity: System x
    Dahlmanns M; Dahlmanns JK; Savaskan N; Steiner HH; Yakubov E
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):57. PubMed ID: 37005761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CRL3
    Zhou Q; Yu H; Chen Y; Ren J; Lu Y; Sun Y
    Proc Natl Acad Sci U S A; 2024 Jul; 121(28):e2320655121. PubMed ID: 38959043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simple Fluorescence Assay for Cystine Uptake via the xCT in Cells Using Selenocystine and a Fluorescent Probe.
    Shimomura T; Hirakawa N; Ohuchi Y; Ishiyama M; Shiga M; Ueno Y
    ACS Sens; 2021 Jun; 6(6):2125-2128. PubMed ID: 34080411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystine/glutamate antiporter xCT controls skeletal muscle glutathione redox, bioenergetics and differentiation.
    Kanaan MN; Pileggi CA; Karam CY; Kennedy LS; Fong-McMaster C; Cuperlovic-Culf M; Harper ME
    Redox Biol; 2024 Jul; 73():103213. PubMed ID: 38815331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis.
    Dixon SJ; Patel DN; Welsch M; Skouta R; Lee ED; Hayano M; Thomas AG; Gleason CE; Tatonetti NP; Slusher BS; Stockwell BR
    Elife; 2014 May; 3():e02523. PubMed ID: 24844246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.
    Huang Y; Dai Z; Barbacioru C; Sadée W
    Cancer Res; 2005 Aug; 65(16):7446-54. PubMed ID: 16103098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ROS Mediate xCT-Dependent Cell Death in Human Breast Cancer Cells under Glucose Deprivation.
    Chen MC; Hsu LL; Wang SF; Hsu CY; Lee HC; Tseng LM
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
    Jyotsana N; Ta KT; DelGiorno KE
    Front Oncol; 2022; 12():858462. PubMed ID: 35280777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
    Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment.
    He J; Wang X; Chen K; Zhang M; Wang J
    Biochem Pharmacol; 2022 Nov; 205():115241. PubMed ID: 36084707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.
    Liu X; Zhang Y; Zhuang L; Olszewski K; Gan B
    Genes Dis; 2021 Nov; 8(6):731-745. PubMed ID: 34522704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the effects of polyunsaturated fatty acids on transporter expressions using a PCR array: Induction of xCT/SLC7A11 in human placental BeWo cells.
    Ono K; Furugen A; Kurosawa Y; Jinno N; Narumi K; Kobayashi M; Iseki K
    Placenta; 2019 Jan; 75():34-41. PubMed ID: 30712664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. xCT (SLC7A11) expression confers intrinsic resistance to physical plasma treatment in tumor cells.
    Bekeschus S; Eisenmann S; Sagwal SK; Bodnar Y; Moritz J; Poschkamp B; Stoffels I; Emmert S; Madesh M; Weltmann KD; von Woedtke T; Gandhirajan RK
    Redox Biol; 2020 Feb; 30():101423. PubMed ID: 31931281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TGF-β1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells.
    Kim DH; Kim WD; Kim SK; Moon DH; Lee SJ
    Cell Death Dis; 2020 May; 11(5):406. PubMed ID: 32471991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperexcitability and brain morphological differences in mice lacking the cystine/glutamate antiporter, system x
    Sears SMS; Roberts SH; Hewett SJ
    J Neurosci Res; 2021 Dec; 99(12):3339-3353. PubMed ID: 34747522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression.
    Ji X; Qian J; Rahman SMJ; Siska PJ; Zou Y; Harris BK; Hoeksema MD; Trenary IA; Heidi C; Eisenberg R; Rathmell JC; Young JD; Massion PP
    Oncogene; 2018 Sep; 37(36):5007-5019. PubMed ID: 29789716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injury.
    Jackman NA; Uliasz TF; Hewett JA; Hewett SJ
    Glia; 2010 Nov; 58(15):1806-15. PubMed ID: 20645408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.